van der Moeren, NZwart, V FGoderski, GRijkers, G Tvan den Bijllaardt, WVeenemans, JKluytmans, J A J WPas, S DMeijer, AVerweij, J JMurk, J L A NStohr, J J J M2021-07-212021-07-212021-07-083427154010.1016/j.jcv.2021.104909http://hdl.handle.net/10029/625163The DAA had an overall specificity of 100% (95%CI 97.9%-100%) and sensitivity of 73% (95%CI 61.3%-82.7%) for the clinical samples. Sensitivity was 86% (CI95% 74.6%-93.3%) for samples with Ct-value below 30. Both the DAA and RRA detected SARS-CoV-2 up to a dilution containing 5.2 × 102 fifty-percent-tissue-culture-infective-dose (TCID50)/ml.enCopyright © 2021. Published by Elsevier B.V.Antigen detection assayEvaluationSARS-CoV-2Article1873-5967J Clin Virol 2021; 141:104909